Lans Holdings, Inc. (OTCPK:LAHO) entered into a binding letter of intent to (LOI) acquire Global Stem Cells Group, Inc. from Benito Novas on May 23, 2019. Under the terms of LOI, Lans Holdings will issue 237,500 shares of Series C Preferred Stock, 8,974 shares of Series D Preferred Stock and will pay an amount of $0.3 million in multiple tranches with the total payment amount being paid in full at the latest upon execution of the Definitive Agreement or at such other date as shall be specified by the parties. The transaction is subject to approval by the Board of Directors and shareholders of Lans Holdings and Global Stem Cells and execution of definitive agreement. As of July 29, 2019, Lans Holdings Inc. has successfully completed its due diligence to acquire Global Stem Cells Group. As of September 11, 2019, Lans Holdings Inc successfully secured a 180-day extension to complete the acquisition of 100% of Global Stem Cells Group Inc. The transaction is expected to close on March 10, 2020.